Inactive Instrument
Sector Human Genome Sciences
Stocks
US4449031081
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 12-07-26 | Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources | RE |
| 12-07-16 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -0.84% | -1.53% | +2.95% | +16.65% | +7.62% | +1.37% | +18.39% | -25.32% | +210.52% | 50.47B | |
| -6.00% | -0.75% | +8.18% | +32.00% | +160.99% | +447.48% | +524.26% | +633.26% | - | 44.56B | |
| -0.24% | +0.74% | +10.08% | +43.65% | +16.12% | +37.18% | +16.57% | +0.06% | +239.32% | 43.08B | |
| -1.55% | -2.07% | +13.86% | +27.37% | +20.71% | +19.83% | +73.63% | +21.51% | +1,153.78% | 41.7B | |
| -0.31% | -0.83% | +0.37% | +3.80% | +10.63% | +19.47% | +48.24% | -20.29% | +156.02% | 33.21B | |
| -1.79% | -3.24% | +3.86% | +34.34% | +6.94% | +26.32% | +121.63% | +225.54% | +2,055.96% | 16.77B | |
| -0.58% | -2.12% | -1.26% | +10.62% | - | - | - | - | - | 16.28B | |
| -0.28% | -1.50% | +5.87% | +16.65% | +15.64% | +11.05% | +26.95% | -39.91% | +98.57% | 14.58B | |
| -1.66% | -1.25% | +24.24% | +61.31% | +46.13% | +78.49% | +39.02% | -34.45% | +245.95% | 13.92B | |
| +0.18% | -1.28% | +2.71% | +24.95% | -6.70% | -4.45% | -35.99% | -33.63% | +121.52% | 13.12B | |
| -9.41% | -11.90% | +44.59% | +26.89% | +8.45% | -15.58% | - | - | - | 11.56B | |
| -0.17% | +0.04% | +0.44% | +40.00% | +23.02% | +32.44% | -9.83% | -42.79% | +176.94% | 11.35B | |
| -2.93% | -8.75% | +21.58% | +74.42% | +53.99% | +44.68% | +44.68% | -49.62% | - | 10.96B | |
| -0.36% | -1.12% | -8.75% | -13.24% | -19.44% | +43.92% | +454.29% | +209.41% | +2,325.00% | 10.58B | |
| +0.01% | +0.16% | +0.50% | +64.32% | +78.82% | +271.10% | +464.73% | - | - | 10.18B | |
| -2.21% | +2.19% | +14.58% | -20.20% | -22.83% | +43.19% | +50.48% | +55.98% | +105.62% | 10.15B | |
| -1.73% | -1.38% | +10.41% | +45.11% | +51.84% | +186.77% | +503.11% | +93.31% | - | 9.82B | |
| -3.26% | +3.86% | +87.60% | +178.16% | +172.79% | +91.09% | +84.33% | -8.31% | +1,454.13% | 9.77B | |
| -6.28% | -8.30% | +12.02% | -1.49% | +16.97% | +657.03% | +1,553.48% | +20.52% | - | 9.63B | |
| Average | -1.62% | -2.00% | +13.36% | +35.02% | +35.65% | +110.63% | +234.00% | +62.83% | +695.28% | 19.08B | |
| Weighted average by Cap. | -1.67% | -1.60% | +10.30% | +30.51% | +38.44% | +104.30% | +178.97% | +93.79% | +584.43% |
- Stock Market
- Stocks
- Stock
- Sector Human Genome Sciences
Select your edition
All financial news and data tailored to specific country editions
